Pierre Payoux Selected Research

Therapeutics

1/2016	Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of Biomarkers.
1/2003	Limitations of current Parkinson's disease therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Payoux Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2012
23	Cognitive Dysfunction 03/2024 - 01/2003
18	Dementia (Dementias) 05/2024 - 08/2015
10	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2003
8	Atrophy 01/2021 - 08/2009
6	Pain (Aches) 01/2019 - 01/2003
5	Neuroinflammatory Diseases 01/2022 - 12/2017
4	Neoplasms (Cancer) 02/2023 - 08/2005
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2023 - 01/2012
4	Disease Progression 01/2019 - 12/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2018
3	Cerebral Hemorrhage 01/2020 - 08/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2024 - 10/2009
2	Brain Injuries (Brain Injury) 01/2023 - 01/2017
2	Brain Diseases (Brain Disorder) 12/2022 - 01/2019
2	Inflammation (Inflammations) 08/2021 - 01/2018
2	Hypertension (High Blood Pressure) 10/2019 - 08/2017
2	Prodromal Symptoms 01/2019 - 06/2013
2	Sleep Deprivation 01/2019 - 01/2018
2	Amyloid Plaque 01/2019 - 12/2017
2	Major Depressive Disorder (Major Depressive Disorders) 01/2018 - 12/2011
2	Parkinsonian Disorders (Parkinsonism) 07/2016 - 12/2011
2	Neoplasm Metastasis (Metastasis) 01/2014 - 08/2008
2	Melanoma (Melanoma, Malignant) 01/2014 - 08/2008
2	Neuralgia (Stump Neuralgia) 05/2013 - 11/2012
1	Narcolepsy 05/2024
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 03/2024
1	Ganglion Cysts (Ganglion) 03/2024
1	Coma (Comas) 02/2024
1	Hypoxia (Hypoxemia) 02/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Virus Diseases (Viral Diseases) 08/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Frailty 10/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Restless Legs Syndrome (Restless Legs) 01/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2019
1	Multiple System Atrophy 01/2019
1	Brain Neoplasms (Brain Tumor) 12/2018
1	Vitamin D Deficiency 01/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 09/2017
1	Hemorrhage 08/2017
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2017
1	Fatigue 01/2017

Drug/Important Bio-Agent (IBA)

34	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2012
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2013
9	florbetapirIBA 04/2024 - 06/2013
5	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2008
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2019 - 05/2003
4	Levodopa (L Dopa)FDA LinkGeneric 07/2016 - 01/2003
3	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 04/2024 - 01/2018
3	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 03/2024 - 01/2019
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2023 - 09/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 05/2013
3	Memantine (Namenda)FDA Link 05/2020 - 05/2013
2	flutemetamolIBA 04/2024 - 03/2024
2	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2018
2	Amyloid beta-PeptidesIBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2015
2	Donepezil (Aricept)FDA LinkGeneric 05/2020 - 01/2018
2	IronIBA 01/2018 - 08/2009
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2017 - 01/2017
2	Pain-FreeIBA 05/2013 - 11/2012
1	OrexinsIBA 05/2024
1	Retinaldehyde (Retinal)IBA 03/2024
1	Rituximab (Mabthera)FDA Link 02/2023
1	HydrogelsIBA 12/2022
1	PPAR gammaIBA 08/2021
1	atezolizumabIBA 01/2021
1	Zirconium-89IBA 01/2021
1	BenzodiazepinesIBA 12/2019
1	Cocaine (Cocaine HCl)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Modafinil (Provigil)FDA Link 01/2019
1	8- ((E)- 4- fluoro- but- 2- enyl)- 3beta- p- tolyl- 8- aza- bicyclo(3.2.1)octane- 2beta- carboxylic acid methyl esterIBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	GABA Receptors (GABA Receptor)IBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2019
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2019
1	SynucleinsIBA 01/2019
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	hydroxide ionIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 12/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 02/2017
1	9-(4-fluoro-3-hydroxymethylbutyl)guanineIBA 01/2017
1	malonic acid (malonate)IBA 01/2017

Therapy/Procedure

2	Cell Transplantation 01/2019 - 01/2017
2	Activities of Daily Living (ADL) 10/2018 - 03/2016
2	Therapeutics 01/2016 - 01/2003
1	Cochlear Implantation 01/2023
1	Denervation 01/2019
1	Radiotherapy 12/2018
1	Cognitive Training 05/2017